**Author details**

Eitan Fibach\* and Mutaz Dana Department of Hematology, Hadassah–Hebrew University Medical Center, Jerusalem, Israel

\*Address all correspondence to: fibach@yahoo.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**59**

*Red Blood Cells as Redox Modulators in Hemolytic Anemia*

spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood

[11] Luzzatto L, Battistuzzi G. Glucose-6 phosphate dehydrogenase. Advances in Human Genetics. 1985;**14**:217, 86-329, 88

[12] Walport MJ. Complement. First of two parts. The New England Journal of Medicine. 2001;**344**(14):1058-1066

[13] Parker CJ. The pathophysiology of paroxysmal nocturnal hemoglobinuria.

[14] Shalev H, Al-Athamen K, Levi I, Levitas A, Tamary H. Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I. European Journal of Haematology. 2017;**98**(1):13-18

[15] Fibach E, Rachmilewitz E. Iron overload in hematological disorders. La Presse Médicale. 2017;**46**(12):e296-e305

[16] Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annual Review of Medicine. 2011;**62**:347-360

[17] Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin—a novel mechanism of human disease. JAMA. 2005;**293**(13):1653-1662

[18] Droge W. Free radicals in the physiological control of cell function. Physiological Reviews. 2002;**82**(1):47-95

[19] Minetti M, Malorni W. Redox control of red blood cell biology: The red blood cell as a target and source of prooxidant species. Antioxidants & Redox Signaling. 2006;**8**(7-8):1165-1169

[20] Mothersill C, Stamato TD, Perez ML, Cummins R, Mooney R, Seymour

Experimental Hematology.

2007;**35**(4):523-533

Reviews. 2013;**27**(4):167-178

*DOI: http://dx.doi.org/10.5772/intechopen.84498*

[2] Rifkind JM, Nagababu E, Ramasamy S, Ravi LB. Hemoglobin redox reactions and oxidative stress. Redox Report.

[3] Kohen R, Nyska A. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology.

[4] Elahian F, Sepehrizadeh Z, Moghimi B, Mirzaei SA. Human cytochrome b5 reductase: Structure, function, and potential applications. Critical Reviews in Biotechnology. 2014;**34**(2):134-143

[5] Martindale JL, Holbrook NJ. Cellular response to oxidative stress: Signaling for suicide and survival. Journal of Cellular Physiology. 2002;**192**(1):1-15

[6] Wolke C, Bukowska A, Goette A, Lendeckel U. Redox control of cardiac remodeling in atrial fibrillation. Biochimica et Biophysica Acta.

[7] Martinez MC, Andriantsitohaina R. Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease. Antioxidants & Redox Signaling. 2009;**11**(3):669-702

[8] Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Current Molecular Medicine.

[9] Weatherall DJ. Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias. Nature Reviews. Genetics. 2001;**2**(4):245-255

Fenneteau O, Mohandas N. Hereditary

[10] Da Costa L, Galimand J,

2015;**1850**(8):1555-1565

2008;**8**(7):609-619

[1] Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. 3rd ed. Midsomer Norton, Avon, England:

Oxford University Press; 1999

**References**

2003;**8**(5):234-237

2002;**30**(6):620-650
